Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,680 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 43 of 640 · 7,680 filings

  • SmartKem (SMTK) FY2025 10-K risk factors
    39 risks3 new7 dropped5 reworded

    SmartKem faces severe financial strain with $125.1 million in accumulated deficit, continuous net losses, and Nasdaq listing deficiencies.

    Filed Apr 08, 2026
  • Virco MFG (VIRC) FY2026 10-K risk factors
    31 risks5 new3 dropped4 reworded

    Virco Mfg Corporation highlights growing risks around artificial intelligence adoption in educational environments, rising healthcare expenses, and evolving trade policies.

    Filed Apr 08, 2026
  • Jaguar Health (JAGX) FY2025 10-K risk factors
    Risk factors section under review

    Series O Preferred Stock dividend and conversion terms dominate the risk section.

    Filed Apr 07, 2026
  • Skillsoft (SKIL) FY2026 10-K risk factors
    49 risks9 new1 dropped12 reworded

    Skillsoft is restructuring its Global Knowledge business while expanding platform investments and AI features.

    Filed Apr 07, 2026
  • iQSTEL (IQST) FY2025 10-K risk factors
    39 risks4 new2 dropped10 reworded

    Auditors warn of going concern doubt as accumulated deficit reaches $43.3 million as of December 31, 2025.

    Filed Apr 06, 2026
  • SolarMax Technology (SMXT) FY2025 10-K risk factors
    53 risks5 new45 dropped10 reworded

    SolarMax faces mounting debt defaults, working capital deficits, and Nasdaq delisting warnings amidst new BESS project execution risks.

    Filed Apr 06, 2026
  • Karman Holdings (KRMN) FY2025 10-K risk factors
    71 risks2 new6 dropped11 reworded

    Customer concentration increased, with the top three customers accounting for 51.5% of revenue in 2025.

    Filed Apr 03, 2026
  • RCM Technologies (RCMT) FY2025 10-K risk factors
    86 risks32 new37 dropped48 reworded

    RCM Technologies faces material weaknesses in internal controls requiring comprehensive remediation.

    Filed Apr 03, 2026
  • Sunshine Biopharma (SBFM) FY2025 10-K risk factors
    12 risks2 new2 dropped3 reworded

    Accumulated deficit grew to $75,015,126 alongside ongoing net losses. Supplier concentration increased with 75% of drug portfolio manufactured by three overseas suppliers. Nasdaq compliance remains precarious despite trading slightly above the $1.00 minimum bid price.

    Filed Apr 03, 2026
  • Caleres (CAL) FY2026 10-K risk factors
    31 risks31 new79 dropped

    Caleres highlights significant risks from new 2025 tariffs on imported footwear, reliance on key suppliers Nike, Skechers, and adidas, and macroeconomic pressures impacting discretionary retail spending.

    Filed Apr 02, 2026
  • ChargePoint Holdings (CHPT) FY2026 10-K risk factors
    59 risks9 new10 dropped20 reworded

    ChargePoint added artificial intelligence compliance, climate reporting, and foreign currency exchange risks to its disclosures.

    Filed Apr 02, 2026
  • Iridex (IRIX) FY2025 10-K risk factors
    Risk factors section under review

    International revenue heavily depends on the Netherlands at 14.7 percent and China at 11.0 percent for fiscal year 2025. Diluted share counts and convertible debt obligations from Novel impact net loss calculations. Financial reporting relies on internal controls with inherent limitations.

    Filed Apr 02, 2026

Companies covered

4,010 companies

371 more under A